Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Poniard Pharmaceuticals, Inc. PARD OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
28/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Financial Health Score — PARD

No financial health data available for PARD.

People Also View

CERE
CERE
Cerevel Therapeutics Holdings, Inc.
$44.96
+0.74%
 CYTK
CYTK
Cytokinetics, Incorporated
$66.35
-0.55%
 SRRK
SRRK
Scholar Rock Holding Corporation
$49.53
+0.02%
 APLS
APLS
Apellis Pharmaceuticals, Inc.
$40.85
+0.02%
 CRNX
CRNX
Crinetics Pharmaceuticals, Inc.
$39.75
+2.82%
 LEGN
LEGN
Legend Biotech Corporation
$18.69
+5.65%
 KDNY
KDNY
Chinook Therapeutics, Inc.
$40.39
+0.22%
 ADPT
ADPT
Adaptive Biotechnologies Corporation
$14.53
+2.83%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message